BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 18516602)

  • 1. Myelodysplastic syndromes: molecular pathogenesis and genomic changes.
    Nolte F; Hofmann WK
    Ann Hematol; 2008 Oct; 87(10):777-95. PubMed ID: 18516602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Important features of myelodysplastic syndrome.
    Hofmann WK; Koeffler HP
    Int J Hematol; 2002 Aug; 76 Suppl 2():222-7. PubMed ID: 12430929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms involved in the progression of myelodysplastic syndrome.
    Nolte F; Hofmann WK
    Future Oncol; 2010 Mar; 6(3):445-55. PubMed ID: 20222800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory anemia and the myelodysplastic syndromes.
    Lawrence LW
    Clin Lab Sci; 2004; 17(3):178-86. PubMed ID: 15314893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis of myelodysplastic syndromes.
    Gallagher A; Darley RL; Padua R
    Haematologica; 1997; 82(2):191-204. PubMed ID: 9175327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelodysplastic syndromes].
    Geissler K
    Wien Med Wochenschr; 1991; 141(9-10):201-4. PubMed ID: 1949844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative review of classification systems in myelodysplastic syndromes (MDS).
    Bennett JM
    Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular bases of myelodysplastic syndromes: lessons from animal models.
    Komeno Y; Kitaura J; Kitamura T
    J Cell Physiol; 2009 Jun; 219(3):529-34. PubMed ID: 19259975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic alterations in myelodysplastic syndrome.
    Mihara K; Takihara Y; Kimura A
    Cytogenet Genome Res; 2007; 118(2-4):297-303. PubMed ID: 18000383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear inositide signaling in myelodysplastic syndromes.
    Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli AM; Cocco L
    J Cell Biochem; 2010 Apr; 109(6):1065-71. PubMed ID: 20058233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification and prognostic evaluation of myelodysplastic syndromes.
    Cazzola M; Della Porta MG; Travaglino E; Malcovati L
    Semin Oncol; 2011 Oct; 38(5):627-34. PubMed ID: 21943669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myelodysplastic syndromes].
    Solary E; Fontenay M
    Rev Prat; 2010 Dec; 60(10):1408-9, 1412. PubMed ID: 21425540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH.
    Oliveira FM; Lucena-Araujo AR; Favarin Mdo C; Palma PV; Rego EM; Falcão RP; Covas DT; Fontes AM
    Exp Hematol; 2013 Feb; 41(2):198-208. PubMed ID: 23092930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear phospholipase C beta1, regulation of the cell cycle and progression of acute myeloid leukemia.
    Cocco L; Manzoli L; Palka G; Martelli AM
    Adv Enzyme Regul; 2005; 45():126-35. PubMed ID: 16024064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, classification, and course of myelodysplastic syndromes.
    McKenna RW; Allison PM
    Clin Lab Med; 1990 Dec; 10(4):683-706. PubMed ID: 2272170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contemporary possibilities of prognosis in myelodysplastic syndromes].
    Goździk J; Lewandowski K; Hansz J
    Acta Haematol Pol; 1995; 26(2):129-38. PubMed ID: 7653217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes.
    Germing U; Aul C; Niemeyer CM; Haas R; Bennett JM
    Ann Hematol; 2008 Sep; 87(9):691-9. PubMed ID: 18575866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
    Preisler HD
    Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular and genetic features of myelodysplastic syndromes.
    Greenberg PL
    Int J Lab Hematol; 2012 Jun; 34(3):215-22. PubMed ID: 22212119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.